Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Nov 12;5(11):2138-60.
doi: 10.3390/toxins5112138.

Clostridium perfringens epsilon toxin: a malevolent molecule for animals and man?

Affiliations
Review

Clostridium perfringens epsilon toxin: a malevolent molecule for animals and man?

Bradley G Stiles et al. Toxins (Basel). .

Abstract

Clostridium perfringens is a prolific, toxin-producing anaerobe causing multiple diseases in humans and animals. One of these toxins is epsilon, a 33 kDa protein produced by Clostridium perfringens (types B and D) that induces fatal enteric disease of goats, sheep and cattle. Epsilon toxin (Etx) belongs to the aerolysin-like toxin family. It contains three distinct domains, is proteolytically-activated and forms oligomeric pores on cell surfaces via a lipid raft-associated protein(s). Vaccination controls Etx-induced disease in the field. However, therapeutic measures are currently lacking. This review initially introduces C. perfringens toxins, subsequently focusing upon the Etx and its biochemistry, disease characteristics in various animals that include laboratory models (in vitro and in vivo), and finally control mechanisms (vaccines and therapeutics).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Crystal structures of C. perfringens epsilon toxin, C. perfringens enterotoxin, L. sulphureus lectin and A. hydrophila aerolysin. A basic, three-domain structure is evident for each protein [30,34,35,36,37]. Amino acids involved in pore-formation are in red.

References

    1. Songer J.G. Clostridial enteric diseases of domestic animals. Clin. Microbiol. Rev. 1996;9:216–234. - PMC - PubMed
    1. McDonel J.L. Clostridium perfringens toxins (Type A, B, C, D, E) Pharmacol. Ther. 1980;10:617–655. doi: 10.1016/0163-7258(80)90031-5. - DOI - PubMed
    1. Oakley C.L., Warrack G.H. Routine typing of Clostridium welchii. J. Hyg. Camb. 1953;51:102–107. doi: 10.1017/S0022172400015527. - DOI - PMC - PubMed
    1. Goldstein M.R., Kruth S.A., Bersenas A.M., Holowaychuk M.K., Weese J.S. Detection and characterization of Clostridium perfringens in the feces of healthy and diarrheic dogs. Can. J. Vet. Res. 2012;76:161–165. - PMC - PubMed
    1. Albini S., Brodard I., Jaussi A., Wollschlaeger N., Frey J., Miserez R., Abril C. Real-time multiplex PCR assays for reliable detection of Clostridium perfringens toxin genes in animal isolates. Vet. Microbiol. 2008;127:179–185. doi: 10.1016/j.vetmic.2007.07.024. - DOI - PubMed

Substances

LinkOut - more resources